Chief Scientific Officer of OPIANT PHARMACEUTICALS, INC. (U.S.: Nasdaq:OPNT), Skolnick Phil, sells 385 shares worth $11,739

According to OPIANT PHARMACEUTICALS, INC.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 04:37 PM, company Chief Scientific Officer, Skolnick Phil disclosed selling 385 shares at a cost of $30.49. At the time of this transaction (Jan 10), this trade was worth $11,739 in total. As of Jan 10, Skolnick Phil now owns 23,963 shares in total worth about $706,429.24.

For the last few recent trades made by OPIANT PHARMACEUTICALS, INC. (U.S.: Nasdaq:OPNT) Chief Scientific Officer, Skolnick Phil, we have the following information:

Posted by George Daniels on Thursday January 13 2022, 2:02 PM EST. All trademarks acknowledged. Filed under Business, Stocks. Comments and Trackbacks closed. Follow responses: RSS 2.0